More about

Car T-Cell Therapy

News
January 12, 2023
3 min watch
Save

VIDEO: Where to focus future DLBCL research

VIDEO: Where to focus future DLBCL research

Healio spoke with Joshua Brody, MD, about unmet needs and distinct challenges, as well as the treatment landscape in diffuse large B-cell lymphoma.

News
January 12, 2023
5 min watch
Save

VIDEO: Understanding enrollment, racial disparities in DLBCL clinical trials

VIDEO: Understanding enrollment, racial disparities in DLBCL clinical trials

Healio spoke with Joshua Brody, MD, about unmet needs and distinct challenges, as well as the treatment landscape in diffuse large B-cell lymphoma.

News
January 12, 2023
4 min watch
Save

VIDEO: Research updates in DLBCL

VIDEO: Research updates in DLBCL

Healio spoke with Joshua Brody, MD, about unmet needs and distinct challenges, as well as the treatment landscape in diffuse large B-cell lymphoma.

News
January 05, 2023
5 min watch
Save

Fourth-generation autologous CAR-T product shows efficacy for pretreated lymphoma

Fourth-generation autologous CAR-T product shows efficacy for pretreated lymphoma

NEW ORLEANS — A novel chimeric antigen receptor T-cell therapy showed encouraging early efficacy among heavily pretreated patients with CD19-positive non-Hodgkin lymphoma, according to study results.

News
January 04, 2023
5 min watch
Save

Bendamustine lymphodepletion effective, safe as part of CAR-T for advanced lymphoma

Bendamustine lymphodepletion effective, safe as part of CAR-T for advanced lymphoma

NEW ORLEANS — Bendamustine lymphodepletion resulted in significant CAR T-cell expansion among patients with relapsed or refractory non-Hodgkin lymphoma, according to study results presented at ASH Annual Meeting and Exposition.

News
December 30, 2022
2 min read
Save

BLOG: CAR T cells for long-term cure in pediatric ALL

BLOG: CAR T cells for long-term cure in pediatric ALL

Chimeric antigen receptor T-cell therapy targeting CD19 is highly effective for inducing remission among patients with relapsed or refractory B-cell acute lymphoblastic leukemia.

News
December 28, 2022
3 min watch
Save

VIDEO: Advances in CAR T-cell manufacturing, real-world data highlighted at ASH

VIDEO: Advances in CAR T-cell manufacturing, real-world data highlighted at ASH

NEW ORLEANS — Making chimeric antigen receptor T cells quickly is going to become a reality, according to Nikhil C. Munshi, MD, who discusses presentations from the ASH Annual Meeting and Exposition in this video perspective.

News
December 28, 2022
3 min read
Save

Recent exposure to chemotherapy drug linked to worse outcomes among CAR-T recipients

Recent exposure to chemotherapy drug linked to worse outcomes among CAR-T recipients

NEW ORLEANS — Patients recently treated with bendamustine had significantly lower response rates to subsequent chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma, data presented at ASH Annual Meeting and Exposition showed.

News
December 20, 2022
3 min read
Save

Study of CAR-T for patients with non-Hodgkin lymphoma, HIV yields 'reassuring' results

Study of CAR-T for patients with non-Hodgkin lymphoma, HIV yields 'reassuring' results

NEW ORLEANS — Chimeric antigen receptor T cells demonstrated acceptable efficacy with no additional safety concerns when administered to patients with non-Hodgkin lymphoma and HIV, retrospective study results showed.

News
December 20, 2022
1 min watch
Save

VIDEO: New CAR-T targets show activity

VIDEO: New CAR-T targets show activity

NEW ORLEANS — In this video perspective, Samer Al Hadidi, MD, MS, FACP, discusses research evaluating G protein–coupled receptor as a new target for therapy in relapsed refractory multiple myeloma.

View more